Home/Filings/4/0001213900-25-112942
4//SEC Filing

Manieu Alexandre Weinstein 4

Accession 0001213900-25-112942

CIK 0001158780other

Filed

Nov 19, 7:00 PM ET

Accepted

Nov 20, 11:35 AM ET

Size

19.6 KB

Accession

0001213900-25-112942

Insider Transaction Report

Form 4
Period: 2025-10-29
Transactions
  • Award

    Common Stock

    2025-02-25+10,25010,250 total
  • Award

    Common Warrants

    2025-01-23+84,59984,599 total(indirect: Indirectly held through Chutzpah Holdings Limited)
    Exercise: $5.57From: 2025-06-30Common Shares (0 underlying)
  • Exercise/Conversion

    Common Stock

    2025-10-29$0.00/sh+1,002,169$1001,933,415 total(indirect: Shares indirectly held through Chutzpah Holdings Limited)
  • Exercise/Conversion

    Pre-Funded Warrants to purchase Common Shares

    2025-10-291,002,16984,599 total(indirect: Indirectly held through Chutzpah Holdings Limited)
    Exercise: $0.00From: 2025-06-30Common Shares (0 underlying)
  • Purchase

    Common Stock

    2025-04-28$4.61/sh+452,702$2,086,956452,702 total(indirect: Shares indirectly held through Plantae Bioscience Ltd.)
Transactions
  • Purchase

    Common Stock

    2025-04-28$4.61/sh+452,702$2,086,956452,702 total(indirect: Shares indirectly held through Plantae Bioscience Ltd.)
  • Exercise/Conversion

    Common Stock

    2025-10-29$0.00/sh+1,002,169$1001,933,415 total(indirect: Shares indirectly held through Chutzpah Holdings Limited)
  • Exercise/Conversion

    Pre-Funded Warrants to purchase Common Shares

    2025-10-291,002,16984,599 total(indirect: Indirectly held through Chutzpah Holdings Limited)
    Exercise: $0.00From: 2025-06-30Common Shares (0 underlying)
  • Award

    Common Warrants

    2025-01-23+84,59984,599 total(indirect: Indirectly held through Chutzpah Holdings Limited)
    Exercise: $5.57From: 2025-06-30Common Shares (0 underlying)
  • Award

    Common Stock

    2025-02-25+10,25010,250 total
Footnotes (7)
  • [F1]This statement is jointly filed by and on behalf of each of Chutzpah Holdings Limited ("Chutzpah") and Mr. Weinstein. Mr. Weinstein indirectly owns 100% of Chutzpah and may be deemed to beneficially own securities owned by Chutzpah.
  • [F2]Mr. Weinstein indirectly owns 77% of Plantae Bioscience Ltd. ("Plantae") and may be deemed to beneficially own securities owned by Plantae. Neither the filing of this statement nor anything herein shall be deemed an admission that Mr. Weinstein is, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the beneficial owner of any securities owned by Plantae. Mr. Weinstein disclaims beneficial ownership of such securities covered by this statement, except to the extent of his pecuniary interest in such securities. Each reporting person declares that neither the filing of this statement nor anything herein shall be construed as an admission that such person is, for the purposes of Section 13(d) or13(g) of the Act or any other purpose, a member of a group with respect to the issuer or securities of the issuer.
  • [F3]In connection with the issuance of common shares in a private placement transaction to Chutzpah on January 23, 2025 (previously reported by the reporting person on Form 3 filed with the Securities and Exchange Commission on February 18, 2025), the reporting person also received 26,030 prefunded warrants to purchase common shares, which, together with the 976,139 prefunded warrants to purchase common shares issued on April 25, 2025 under an amendment to its previously executed Securities Purchase Agreement, entered into on January 23, 2025 by the Company and Chutzpah, became exercisable following the Company's shareholders meeting on June 30, 2025. The total number of pre-funded warrants being reported after being exercised by the reporting person is 1,002,169 consisting of 976,139 plus 26,030 pre-funded warrants.
  • [F4]On January 23, 2025, Pluri Inc. ("Pluri") entered into a Securities Purchase Agreement with Chutzpah, relating to a private placement offering of: (i) 1,383,948 common shares, par value $0.00001 per share of Pluri, (ii) pre-funded warrants to purchase up to 26,030 Common Shares, and (iii) common warrants to purchase up to 84,599 common shares. The reporting person had previously omitted filing a transaction that occurred on January 1, 2025, which was inadvertently omitted from a prior Form 4. The reporting person became aware of the omission on October 31,2025 and is reporting the transaction promptly after such discovery.
  • [F5]1,002,169 pre-funded warrants are being exercised.
  • [F6]The common warrants are exercisable until June 30, 2028.
  • [F7]Pre-Funded Warrants were acquired in exchange for common shares. Common Warrants were issued as part of the January 23, 2025 transaction for no additional consideration.

Documents

1 file

Issuer

Pluri Inc.

CIK 0001158780

Entity typeother

Related Parties

1
  • filerCIK 0001833124

Filing Metadata

Form type
4
Filed
Nov 19, 7:00 PM ET
Accepted
Nov 20, 11:35 AM ET
Size
19.6 KB